Fermentalg SA (FRA:1F6)

Market Cap	41.13M +33.6%
Revenue (ttm)	12.78M +59.1%
Net Income	-11.54M
EPS	-0.12
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	701
Open	0.4815
Previous Close	0.4765
Day's Range	0.4560 - 0.4815
52-Week Range	0.2850 - 0.6250
Beta	n/a
RSI	48.58
Earnings Date	Jan 28, 2026

About Fermentalg

Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 2009 and is headquartered in Libourne, France.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2009
• Employees: 63
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1F6

Financial Performance

In 2024, Fermentalg's revenue was 11.50 million, an increase of 183.39% compared to the previous year's 4.06 million. Losses were -12.88 million, -8.99% less than in 2023.